KDR and cancer: Targeting multiple kinases to simultaneously block VEGFR-, FGFR-, and CSF1R-mediated pathways may be a more effective method of preventing tumor angiogenesis and tumor immune evasion, and therefore represents an attractive anti-cancer therapy approach.